Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
13.95
+0.33 (2.42%)
At close: Jan 22, 2025, 4:00 PM
14.00
+0.05 (0.36%)
After-hours: Jan 22, 2025, 6:13 PM EST
Liquidia Revenue
Liquidia had revenue of $4.45M in the quarter ending September 30, 2024, with 20.94% growth. This brings the company's revenue in the last twelve months to $15.61M, down -14.78% year-over-year. In the year 2023, Liquidia had annual revenue of $17.49M with 9.75% growth.
Revenue (ttm)
$15.61M
Revenue Growth
-14.78%
P/S Ratio
66.09
Revenue / Employee
$107,655
Employees
145
Market Cap
1.18B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
LQDA News
- 2 months ago - Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay Off - Seeking Alpha
- 2 months ago - Liquidia Corporation (LQDA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent - GlobeNewsWire
- 4 months ago - The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Liquidia Corporation - Accesswire
- 4 months ago - Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606) - GlobeNewsWire
- 4 months ago - Liquidia Corporation Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Help The Schall Law Firm - Accesswire
- 4 months ago - Liquidia Corporation Is Being Investigated For Violating Securities Laws And Impacted Investors Are Encouraged To Contact The Schall Law Firm - Accesswire